A made-to-order medicine needs its own explanation.

There can be a patient need

Drug products undergo review by the Food and Drug Administration (FDA). The agency says compounding may fill a patient need left unmet by an approved product.

Ask what need is being met in your case. Have the clinician (a doctor or other health professional) explain why the proposed change matters.

The finished preparation has a different status

The FDA does not approve compounded preparations. It does not review their safety, quality, or effectiveness before sale.

A larger medicine-making site can register with the FDA, meaning it gives the agency its business details. That does not give its products FDA approval.

Routine copies are restricted

Federal law restricts the routine preparation of copies of medicines sold commercially. For a pharmacist or doctor, a change can fall outside that copy rule if the prescriber finds it makes a meaningful difference for the named patient.

An allergy to a dye in the ready-made product can be a reason to prepare a medicine for an individual patient. Ask whether the change solves a specific need like that in your case.

A cheaper price alone is not that kind of difference. Large medicine-making sites have a separate rule restricting copies of approved medicines.

Ask the prescriber what is being changed and why that change matters for you. Ask the pharmacy which copy rule it is using. That explanation answers the copy question, not every rule for making the medicine.

A local stock problem is not the national rule

The national shortage list is kept by the FDA. A pharmacy running out locally does not put a medicine on that list.

At the September 26, 2026 check, semaglutide injections and tirzepatide were not on the FDA’s shortage list.

Adding a vitamin leaves the copy rule to check

An injection may still count as a copy under FDA rules even with a vitamin added, the agency says. This can apply when the main ingredient stays the same and its strength is roughly the same.

One FDA example combines semaglutide with vitamin B12. It can count as a copy when the amounts are within 10 percent of the ready-made products’ strengths and it is given the same way.

Strength means how much medicine is in a given amount of liquid. Ask the pharmacist to compare the proposed product with the approved one and explain the copy rule.

Ask why the change matters for you, and ask for the pharmacy’s name. Keep the cost question separate from the explanation of the medicine.